Journal home
Advance online publication
Current issue
Archive
Press releases
Free Association (blog)
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Biotechnology
Nature Cell Biology
Nature Medicine
Nature Methods
Nature Reviews Cancer
Nature Reviews Genetics
Nature Reviews Molecular Cell Biology
news@nature.com
Nature Conferences
Nature Reports Stem Cells
RNAi Gateway
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Genetics  7, 98 - 102 (1994)
doi:10.1038/ng0594-98

Mutations of the E−cadherin gene in human gynecologic cancers

John I. Risinger1, Andrew Berchuck2, Matthew F. Kohler2 & Jeff Boyd1, 3

  1Gynecologic Pathobiology Group, Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, P.O. Box 12233, Research Triangle Park, North Carolina 27709, USA

  2Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina 27710, USA

  3Correspondence should be addressed to J.B.

Expression of the E−cadherin cell adhesion molecule is reduced in several types of human carcinomas, and the protein serves as an invasion suppressor in vitro. To determine if mutations of the E−cadherin gene (on chromosome 16q22) contribute to epithelial tumorigenesis, 135 carcinomas of the endometrium and ovary were examined for alterations in the E−cadherin coding region. Four mutations were identified: one somatic nonsense and one somatic missense mutation, both with retention of the wild−type alleles, and two missense mutations with somatic loss of heterozygosity in the tumour tissue. These data support the classification of E−cadherin as a human tumour suppressor gene.

REFERENCES
  1. Fearon, E.R. et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247, 49−56 (1990).
  2. Höhne, M.W., Halatsch, M.-E., Kahl, G.F. & Weinel, R.J. Frequent loss of expression of the potential tumor suppressor gene DCC in ductal pancreatic adenocarcinoma. Cancer Res. 52, 2616−2619 (1992).
  3. Gao, X., Honn, K.V., Grignon, D., Sakr, W. & Chen, Y.Q. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinoma. Cancer Res. 53, 2723−2727 (1993).
  4. Edelman, G.M. Morphoregulatory molecules. Biochemistry 27, 3533−3543 (1988).
  5. Takeichi, M. Cadherins: a molecular family important in selective cell-cell adhesion. Annu. Rev. Biochem. 59, 237−252 (1990).
  6. Mahoney, P.A. et al. The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily. Cell 67, 853−868 (1991).
  7. Shimoyama, Y. et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res. 49, 2128−2133 (1989).
  8. Nagafuchi, A., Shirayoshi, Y., Okazaki, K., Yasuda, K. & Takeichi, M. Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature 329, 341−343 (1987).
  9. Behrens, J., Mareel, M.M., Van Roy, F.M. & Birchmeier, W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell Biol. 108, 2435−2447 (1989).
  10. Frixen, U.H. et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113, 173−185 (1991).
  11. Vleminckx, K., Vakaet, L., Mareel, M., Fiers, W. & Van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66, 107−119 (1991).
  12. Shimoyama, Y. & Hirohashi, S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res. 51, 2185−2192 (1991).
  13. Bussemakers, M.J.G. et al. Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res. 52, 2916−2922 (1992).
  14. Umbas, R. et al. Expression of the cellular adhesion molecule E-cadherin Is reduced or absent in high-grade prostate cancer. Cancer Res. 52, 5104−5109 (1992).
  15. Brabant, G. et al. E-Cadherin: A differentiation marker in thyroid malignancies. Cancer Res. 53, 4987−4993 (1993).
  16. Bringuier, P.P. et al. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res. 53, 3241−3245 (1993).
  17. Inoue, M., Ogawa, H., Miyata, M., Shiozaki, H. & Tanizawa, O. Expression of E-cadherin in normal, benign, and malignant tissues of female genital organs. Am. J. clin. Pathol. 98, 76−80 (1992).
  18. Mansouri, A., Spurr, N., Goodfellow, P.N. & Kemler, R. Characterization and chromosomal localization of the gene encoding the human cell adhesion molecule uvomorulin. Differentiation 38, 67−71 (1988).
  19. Natt, E., Magenis, R.E., Zimmer, J., Mansouri, A. & Scherer, G. Regional assignment of the human loci for uvomorulin (UVO) and chymotrypsinogen B (CTRB) with the help of two overlapping deletions on the long arm of chromosome 16. Cytogonet. Cell Genet. 50, 145−148 (1989).
  20. Carter, B.S. et al. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. natn. Acad. Sci. U.S.A. 87, 8751−8755 (1990).
  21. Bergerheim, U.S.R., Kunimi, K., Collins, V.P. & Ekman, P. Deletion mapping of chromosomes 8,10, and 16 in human prostatic carcinoma. Genes Chrom. Cancer 3, 215−220 (1991).
  22. Kunimi, K., Bergerheim, U.S.R., Larsson, I.-L., Ekman, P. & Collins, V.P. Allelotyping of human prostatic adenocarcinoma. Genomics 11, 530−536 (1991).
  23. Sato, T., Saito, H., Morita, R., Koi, S., Lee, J.-H. & Nakamura, Y. Allelotype of human ovarian cancer. Cancer Res. 51, 5118−5122 (1991).
  24. Devilee, P. et al. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 6, 1705−1711 (1991).
  25. Tsuda, H. et al. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. natn. Acad. Sci. U.S.A. 87, 6791−6794 (1990).
  26. Bussemakers, M.J.G., Mees, S.G.M., Van Bokhoven, A., Debruyne, F.M.J. & Schalken, J.A. Molecular cloning and characterization of the human E-cadherin cDNA. Molec. Biol. Rep. 17, 123−128 (1993).
  27. Oda, T. et al. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc. natn. Acad. Sci. U.S.A. 91, 1858−1862 (1994).
  28. Hoffman, S. & Edelman, G.M. Kinetics of homophilic binding by E and A forms of the neural cell adhesion molecule. Proc. natn. Acad. Sci. U.S.A. 80, 5762−5766 (1983).
  29. Doherty, P. et al. A threshold effect of the major isoforms of NCAM on neurite outgrowth. Nature 343, 464−466 (1990).
  30. Sasaki et al. Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res. 53, 1906−1910 (1993).
  31. Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenot-chloroform extraction. Anal. Biochem. 162, 156−159 (1983).
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Genetics
ISSN: 1061-4036
EISSN: 1546-1718
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1994 Nature Publishing Group | Privacy policy